The largest event on Lymphomas and CLL in Latin America!

April 27-30, 2022

Access online event

About the Conference

Join

In 11 editions, the Brazilian Lymphoma Conference has been consolidated as one of the most traditional events in global Hematology. Over the years, it has revealed and debated the latest studies related to lymphomas and chronic lymphocytic leukemia, in addition to addressing advances and novelties in so-called “smart” treatments.

According to the hematologist Dr. Carlos Chiattone, who chairs and organizes the event annually, the BLC has become an important milestone for the multidisciplinary care of patients and professionals in the area, with renowned specialists from the national and international scenarios. Previous editions exceeded the expectations of the organizers. 

“We know how important it is for us to hold these meetings and, even in 2021 at the height of the pandemic that made traditional face-to-face meetings impossible, even in digital format, we could not fail to meet to discuss the current scenario, the latest research, progress, and the evolution of treatments. Certainly, the Brazilian Lymphoma Conference is already a milestone for ABHH”, praises Dr. Chiattone.

PRESIDENT

Carlos Sérgio Chiattone

FCM da Santa Casa de São Paulo e Hospital Samaritano - SP

ORGANIZING COMMITTE

Guilherme Perini

Hospital Israelita Albert Einstein e Grupo Américas

ORGANIZING COMMITTE

Jorge Vaz Pinto Neto

Cettro (Centro de Cancer de Brasília)

ORGANIZING COMMITTE

Natalia Zing

BP A Beneficência Portuguesa de São Paulo

ORGANIZING COMMITTE

Talita Silveira

AC Camargo Cancer Center

ORGANIZING COMMITTE

Thais Fisher

AC Camargo Cancer Center

Speakers

Alvaro Alencar

Andreas Kiesbye Øvlisen

Andrés Ferreri

Anna Sureda

Carla Casulo

Carsten Niemann

Craig Moskowitz

Danielle Leão

Diego Villa Clé

Emanuele Zucca

Georg Hess

Graham Collins

Irene Biasoli

Javier Muñoz

John Kuruvilla

John Leonard

José Cabeçadas

Katharine Lewis

Kerry J. Savage

Laura Fogliatto

Marcelo Capra

Marcio Nucci

Maria Gomes da Silva

Martin Dreyling

Matthew Matasar

Morie Gertz

Natalia Zing

Otávio Baiocchi

Othman Al-Sawaf

Owen O'Connor

Paolo Ghia

Pier Luigi Zinzani

Rafael Gaiolla

Renato Cunha

Rory MacCulloch

Sridhar Chaganti

Stefano Luminari

Stefano Pileri

Thais Fischer

Won Seog Kim

Registration

Open

Non-member

R$150,00 *

  • * Registration will only be effective after payment has been confirmed.
    You must use the email and password you registered to access the conference-broadcasting plataform.

Scientific Programme

Wednesday, April 27th, 2022 – 1st day
Start - End Title Speaker
13:30 - 13:45 Abertura / Opening Presidente / President ABHH: José Francisco Comenalli Marques Jr. (Campinas, SP) Presidente / President BLC: Carlos Sérgio Chiattone (São Paulo, SP)
13:45 - 14:30 Sessão / Session 1: Linfomas Agressivos / Agressive Lymphomas I
13:45 - 13:50 Introdução / Introduction Moderador / Moderator: Guilherme Perini (São Paulo, SP)
13:50 - 14:10 Linfoma difuso de células B e a nova categoria de linfoma de células B de alto grau: atualização /Diffuse B-cell lymphoma and the new high-grade B-cell lymphoma category: an update Palestrante / Speaker: José Cabeçadas (Lisboa, PT)
14:10 - 14:30 Tratamento de primeira linha para DLBCL: o R-CHOP finalmente foi superado? / DLBCL first-line treatment: has R-CHOP finally been surpassed? Palestrante / Speaker: Graham Collins (Oxford, UK)
14:30 - 15:15 Sessão / Session 2: Linfomas Agressivos / Agressive Lymphomas II
14:30 - 14:35 Introdução / Introduction Moderador / Moderator: Daniel Tabak (Rio de Janeiro, RJ)
14:35 - 14:55 Sequenciamento de terapia em Linfoma Difuso de Grandes Células B recidivado/refratário / Therapy sequencing in relapsed/refractory Diffuse Large B-cell Lymphoma Palestrante / Speaker: John Leonard (New York, US)
14:55 - 15:15 Linfoma de Células B Primário do Mediastino: fatores prognósticos e abordagens terapêuticas / Primary Mediastinal B-cell Lymphoma: prognostic factors and therapeutic approaches Palestrante / Speaker: Kerry. J. Savage (Vancouver, CA)
15:15 - 15:20 Intervalo / Break
15:20 - 15:50 Perguntas & respostas ao vivo /Live questions & answers session Participants: palestrantes e moderadores das sessões 1 e 2 / speakers and moderators of sessions 1 and 2
15:50 - 16:00 Intervalo / Break
16:00 - 16:45 Simpósio Corporativo / Corporate Symposium – Roche
Atualizações sobre as abordagens de tratamento no linfoma difuso de grandes células B recém diagnosticado / Updates on Treatment Approaches in Newly Diagnosed Diffuse Large B-Cell Lymphoma
Palestrantes / Speakers: Laura Fogliatto (Porto Alegre, RS) e Matthew Jason Matasar (New York, US)
16:45 - 17:30 Sessão / Session 3: Linfomas & Sistema Nervoso Central / Lymphomas & CNS
16:45 - 16:50 Introdução / Introduction Moderador / Moderator: Talita Silveira (São Paulo, SP)
16:50 - 17:10 Profilaxia do SNC para linfomas agressivos: chegamos a uma conclusão final? Há uma recomendação de consenso para 2022? / CNS Prophylaxis for aggressive lymphomas: have we come to a final conclusion? Is there a consensus recommendation for 2022? Palestrante / Speaker: Katharine Lewis (Perth, AUS)
17:10 - 17:30 Tratamento do Linfoma Primário do SNC: o que há de novo? / Primary CNS Lymphoma treatment: what is new? Palestrante / Speaker: Andrés Ferreri (Milan, IT)
17:30 - 18:15 Sessão / Session 4: Linfomas em Idosos / Lymphomas in Elderly
17:30 - 17:35 Introdução / Introduction Moderador / Moderator: Juliana Pereira (São Paulo, SP)
17:35 - 17:55 LDGCB no idoso: como avaliar e como tratar? / DLBCL in the elderly: how to evaluate and how to treat? Palestrante / Speaker: Stefano Luminari (Modena, IT)
17:55 - 18:15 Linfoma de Hodgkin em idosos: resultados e o papel das novas abordagens / Hodgkin Lymphoma in the elderly: outcomes and the role of novel approaches Palestrante / Speaker: John Kuruvilla (Toronto, CA)
18:15 - 18:20 Intervalo / Break
18:20 - 18:50 Perguntas & Respostas ao vivo / Questions & Answers Live Participantes / Participants: Palestrantes e Moderadores das Sessões 3 e 4 / Speakers and Moderators of the Sessions 3 and 4
18:50 - 19:35 Sessão / Session 5: Discussão de Casos Clínicos I / Clinical Cases Discussion I Moderadores / Moderators: Marcia Delamain (Belo Horizonte, MG) e Marcelo Bellesso (São Paulo, SP)
18:50 - 19:05 Caso clínico / Clinical case 1 (Linfoma de Hodgkin & gravidez / Hodgkin Lymphoma & pregnancy) Apresentador / Presenter: Irene Biasoli (Rio de Janeiro, RJ)
19:05 - 19:20 Caso clínico / Clinical case 2 (Linfoma agressivo & insuficiência cardíaca / Aggressive Lymphoma & cardiac insuficiency) Apresentador / Presenter: Rafael Gaiola (Botucatu, SP)
19:20 - 19:30 Caso clínico / Clinical case 3 (Linfoma associado a implante mamário /Breast implant-associated lymphoma) Apresentador / Presenter: Natália Zing (São Paulo, SP)
19:30 - 20:00 Perguntas & Respostas ao vivo / Questions & Answers Live Participantes / Participants: Todos / All
Thursday, April 28th, 2022 – 2nd day
Start - End Title Speaker
12:30 - 13:15 Simpósio Corporativo / Corporate Symposium – Astrazeneca
Profilaxia da COVID-19: Uma abordagem inovadora no manejo dos pacientes hematológicos / COVID-19 prophylaxis: An innovative approach to the management of hematologic patients
Palestrante / Speaker: Márcio Nucci (Rio de Janeiro, RJ)
13:15 - 13:30 Intervalo / Break
13:30 - 14:15 Simpósio Corporativo / Corporate Symposium - Janssen
Futuros caminhos para o tratamento de pacientes de primeira linha com LCM/Future directions for the treatment of 1st line patients with MCL
Georg Hess (Mainz, DE)
14:15 - 15:00 Sessão / Session 6: Linfoma de Células do Manto / Mantle Cell Lymphoma
14:15 - 14:20 Introdução / Introduction Moderador / Moderator: Rony Schaffel (Rio de Janeiro, RJ)
14:20 - 14:40 Terapia de primeira linha para LCM: como escolher entre as opções disponíveis? / First-line therapy for MCL: how to choose from the available options? Palestrante / Speaker: Martin Dreyling (München, DE)
14:40 - 15:00 LCM em recidiva: manejo atual, avanços recentes e direções futuras / Relapsed MCL: current management, recent advances and future directions Palestrante / Speaker: Rory McCulloch (Gloucester, UK)
15:00 - 15:45 Sessão / Session 7: Leucemia Linfocítica Crônica / Chronic Lymphocytic Leukemia
15:00 - 15:05 Introdução / Introduction Moderador / Moderator: Celso Arrais (São Paulo, SP)
15:05 - 15:25 Tratamento de primeira linha da LLC: ainda estamos enfrentando o mesmo dilema “duração fixa ou terapia contínua”? / CLL first-line treatment: are we still facing the same “fixed duration or continuous therapy” dilemma? Palestrante / Speaker: Othman Al-Sawaf (Cologne, DE)
15:25 - 15:45 Quais são minhas percepções sobre o futuro do tratamento da LLC?/ What are my visions for the future of CLL treatment? Palestrante / Speaker: Paolo Ghia (Milan, IT)
15:45 - 15:50 Intervalo / Break
15:50 - 16:20 Perguntas & Respostas ao vivo / Questions & Answers Live Participantes / Participantes: palestrantes e moderadores das sessões 6 e 7 / speakers and moderators of sessions 6 and 7
16:20 - 16:30 Intervalo / Break
16:30 - 17:15 Simpósio Corporativo / Corporate Symposium – Astrazeneca
Leucemia Linfocítica Crônica: Conectando os Últimos Dados à Prática Clínica / Chronic Lymphocytic Leukemia: Connecting the Latest Data to Clinical Practice
Chairman: Carlos Chiattone (São Paulo – SP) Debatedores / Debaters: Natália Zing (São Paulo – SP) e John Allan (New York, US)
17:15 - 18:00 Sessão / Session 8: Linfoma Folicular / Follicular Lymphoma
17:15 - 15:20 Introdução / Introduction Moderador / Moderator: Adriana Scheliga (Rio de Janeiro, RJ)
17:20 - 17:40 Insights práticos sobre terapia de primeira linha para o Linfoma Folicular: qual é a melhor para os pacientes? / Practical Insights into first-line therapy for Follicular Lymphoma: what’s the best for patients? Palestrante / Speaker: Martin Dreyling (München, DE)
17:40 - 18:00 Tratamento do Linfoma Folicular recidivado: “o mesmo para todos”? /Relapsed Follicular Lymphoma treatment: does “one size fits all”? Palestrante / Speaker: Carla Casulo (Rochester, US)
18:00 - 18:45 Sessão / Session 9: Linfomas de Células T Periféricas (LCTP) / Peripheral T-cell Lymphomas
18:00 - 18:05 Introdução / Introduction Moderador / Moderator: Carlos Chiattone (São Paulo, SP)
18:05 - 18:25 É hora de mudar a prática no tratamento dos linfomas nodais primários de células T periféricas / Is it time to change practice in the treatment of nodal PTCL? Palestrante / Speaker: Owen O’Connor (Charlottesville, USA)
18:25 - 18:45 Como tratar o linfoma extranodal de células T/NK tipo nasal? / How do I treat extranodal NK/T-cell lymphoma nasal type? Palestrante / Speaker: Won Seog Kim (Seoul, KOR)
18:45 - 18:50 Intervalo / Break
18:50 - 19:20 Perguntas & Respostas ao vivo / Questions & Answers Live Participantes / Participantes: palestrantes e moderadores das sessões 8 e 9 / speakers and moderators of sessions 8 and 9
19:20 - 19:30 Intervalo / Break
19:30 - 20:15 Simpósio Corporativo / Corporate Symposium – Zodiac Linfoproliferações crônicas de células B: diagnóstico e tratamento / Chronic B-cell lymphoproliferative disorders: diagnosis and treatment Chairman: Samir Kanaan (Curitiba, PR) Palestrante / Speaker: Javier Muñoz ( Arizona, US)
Friday, April 29th, 2022 – 3rd day
Start - End Title Speaker
12:30 - 13:15 Simpósio Corporativo / Corporate Symposium – Novartis
Como pacientes com linfoma difuso recidivado ou refratário após ao menos duas linhas de terapia sistêmica podem se beneficiar com Kymriah®, a primeira terapia com células CAR-T aprovada no mercado brasileiro./How R/R DLBCL patients with at least 2 prior lines of treatment can benefit from Kymriah®, the first CAR-T cell therapy approved in the Brazilian Market
Moderador / Moderator: Angelo Maiolino (Rio de Janeiro -RJ) Palestrantes / Speakers: André Abrahão (São Paulo – SP) e Lucila Kerbauy (São Paulo – SP)
13:15 - 13:30 Intervalo / Break
13:30 - 14:15 Simpósio Corporativo / Corporate Symposium – MSD
Imunoterapia como um novo paradigma para o tratamento de pacientes com LHc / Immunotherapy as new Treatment Paradigm for cHL patients
Palestrantes / Speakers: Pier Luigi Zinzani (Bologna, IT) e Carlos Sergio Chiattone (São Paulo, SP)
14:15 - 14:25 Intervalo / Break
14:25 - 15:10 Simpósio Corporativo / Corporate Symposium - Kite
Otimizando a seleção de pacientes com linfoma difuso recaído/refratário para terapia com CAR-T/ Optimizing the selection of patients with diffuse relapsed/refractory lymphoma for CAR-T therapy
Palestrantes / Speakers: Maria Gomes da Silva (Lisboa, PT) e Jorge Vaz Pinto Neto (Brasília, DF)
15:10 - 15:20 Intervalo / Break
15:20 - 16:05 Sessão / Session 10: : Linfomas: novas terapias / Lymphoma: novel therapies
15:20 - 15:25 Introdução / Introduction Moderador / Moderator: Jayr Schmidt (São Paulo, SP)
15:25 - 15:45 O papel da terapia com células CAR-T para LDGCB e LCM / The role of CAR-T cell therapy for DLBCL and MCL Palestrante / Speaker: Renato Cunha (Ribeirão Preto, SP)
15:45 - 16:05 A terapia com células CAR-T já é realidade. Qual é a próxima? / CAR-T cell therapy is already in town. What’s next? Palestrante /Speaker: Alvaro Alencar (Miami, US)
16:05 - 16:20 Caso clínico de terapia com células CAR-T: vida real no Brasil / Clinical case of CAR-T cell therapy: real life in Brazil Palestrante / Speaker: Diego Villa Clé (Ribeirão Preto, SP)
16:20 - 17:05 Sessão / Session 11: Linfoma de Hodgkin / Hodgkin Lymphoma
16:20 - 16:25 Introdução / Introduction Moderador/ Moderator: Valéria Buccheri (São Paulo, SP)
16:25 - 16:45 Tratamento do Linfoma de Hodgkin em estágio inicial: quais controvérsias ainda existem? / Management of early-stage Hodgkin Lymphoma: what controversies still exist? Palestrante / Speaker: Otávio Baiocchi (São Paulo, SP)
16:45 - 17:05 Primeira terapia de resgate no Linfoma de Hodgkin: quimioterapia convencional ou novos agentes? / First salvage therapy in Hodgkin Lymphoma: conventional chemotherapy or novel agents? Palestrante / Speaker: Craig Moskowitz (Miami, US)
17:05 - 17:10 Intervalo / Break
17:10 - 17:40 Perguntas & respostas ao vivo /Live questions & answers session Participantes / Participantes: Palestrantes e Moderadores das Sessões 10 e 11 / Speakers and Moderators of the Sessions 10 and 11
17:40 - 17:45 Intervalo / Break
17:45 - 18:30 Simpósio Corporativo / Corporate Symposium – Takeda
Jornada do Paciente con HL em estágio avançado: abordagens de primeira linha e regimes de resgate para transplante / Advanced HL Patient Journey: 1st-line approaches and salvage regimens for transplantation
17:45 - 18:05 Tratamento de primeira linha para cHL: foco em casos avançados / First-line treatment for cHL : Focus on advanced cases Palestrante / Speaker: Otávio Baiocchi (São Paulo, SP)
18:05 - 18:30 Estratégias de resgate antes de HTCT em RRHL /Salvage Strategies before HTCT in RRHL Palestrante / Speaker: Anna Sureda (Barcelona, ES)
Saturday, April 30th, 2022 – 4th day
Start - End Title Speaker
08:00 - 08:45 Sessão / Session 12: Doenças linfoproliferativas: assuntos em evidência / Lymphoproliferative diseases: issues in evidence
08:00 - 08:05 Introdução / Introduction Moderador / Moderator: Sergio Brasil (São Paulo, SP)
08:05 - 08:25 Macroglobulinemia de Waldenstrom: o estado da arte atual / Waldenstrom Macroglobulinemia: the current state of the art Palestrante / Speaker: Morie Gertz (Rochester, US)
08:25 - 08:45 Saúde mental em pacientes com Linfoma Não-Hodgkin: um problema negligenciado / Mental health among patients with Non-Hodgkin Lymphoma: a neglected issue Palestrante / Speaker: Andreas Kiesbye Øvlisen (Aalborg, DK)
08:45 - 09:30 Sessão / Session 13: Linfoma da Zona Marginal e desordens linfoproliferativas pós- transplante (DLPT)/ Marginal Zone Lymphoma and pos-transplant lymphoproliferative disorders (PTLD)
08:45 - 08:50 Introdução / Introduction Moderador / Moderator: Jorge Vaz Pinto Neto (Brasília, DF)
08:50 - 09:10 O que há de novo nos linfomas da Zona Marginal ? / What is New in Marginal Zone Lymphomas? Palestrante / Speaker: Emanuele Zucca (Bellinzona, CH)
09:10 - 09:30 Doença linfoproliferativa pós-transplante: diagnóstico e tratamento / Post-transplant lymphoproliferative disorder: diagnosis and treatment Palestrante / Speaker: Sridhar Chaganti (Birmingham, UK)
09:30 - 09:35 Intervalo / Break
09:35 - 10:05 Perguntas & respostas ao vivo / Live questions & answers session Participantes / Participants: palestrantes e moderadores das sessões 12 e 13 / speakers and moderators of sessions 12 and 13
10:05 - 10:15 Intervalo / Break
10:15 - 11:00 Simpósio Corporativo / Corporate Symposium - Abbvie
Remissão: Quais são os resultados desejados na LLC hoje e amanhã? / Remission: What are desired outcomes in CLL today and tomorrow?
Moderador / Moderator: Laura Campos (São Paulo, SP) Palestrante / Speaker: Carsten Utoft Niemann (Copenhagen, Denmark / Brasília, DF)
11:00 - 11:50 Conferência Magna / Magna Conference
11:00 - 11:05 Introdução / Introduction Moderador / Moderator: Vanderson Rocha (São Paulo, SP)
11:05 - 11:35 Classificação dos linfomas: de onde viemos e para onde vamos? /Lymphomas classification: where did we come from and where are we going? Palestrante / Speaker: Stefano Pileri (Milan, IT)
11:35 - 11:50 Perguntas e respostas ao vivo / Live questions & answers session Participantes / Participantes: Todos / All
11:50 - 12:30 Sessão Hot Topic: / Hot Topic Session
11:50 - 11:55 Introdução / Introduction Moderador / Moderator: Carmino Antonio de Souza (Campinas, SP)
11:55 - 12:15 Neoplasias linfoproliferativas & Covid-19 / Lymphoproliferative neoplasm & Covid-19 Palestrante / Speaker: Marcio Nucci (Rio de Janeiro, RJ)
12:15 - 12:30 Perguntas e respostas ao vivo / Live questions & answers session Participantes / Participantes: Todos / All
12:30 - 13:15 Sessão / Session 14: Discussão de casos clínicos II / Clinical cases discussion II Moderadores / Moderators: Marco Aurélio Salvino (Salvador, BA) e André Abdo (São Paulo, SP)
12:30 - 12:45 Caso Clínico/ Clinical Case 4 (Linfoma Folicular RR, POD 24 positivo / Follicular Lymphoma RR, POD 24 positive) Apresentador / Presenter: Danielle Leão (São Paulo, SP)
12:45 - 13:00 Caso clínico/ Clinical case 5 (Linfoma Cutâneo de Células B Tipo-Perna /Cutaneous B cell Lymphoma Leg-Type) Apresentador/ Presenter: Thais Fisher (São Paulo, SP)
13:00 - 13:15 Caso clínico/Clinical case 6 (Doença de Castleman Multicêntrica Idiopática) / Idiopathic Multicentric Castleman Disease) Apresentador/ Presenter: Marcelo Capra (Porto Alegre, RS)
13:15 - 13:45 Perguntas e respostas ao vivo / Live questions & answers session Participantes / Participantes: Todos / All
13:45 - 14:00 Considerações Finais / Final Remarks Presidente / President BLC: Carlos Chiattone (São Paulo, SP)
*The content of the Corporate Symposia is for prescribers only, following INTERFARMA Resolution.
Link: https://www.interfarma.org.br/app/uploads/2021/03/codigo-de-conduta-revisao-2016-interfarma2.pdf

SIMULTANEOUS TRANSLATION

International speakers’ lectures will be subtitled.

The Live sessions of Questions and Answers will rely on simultaneous translation (English/Portuguese).
Please select the language-corresponding flag on the upper corner of the screen.

General Information

  • - The request for registration cancelation and reimbursement should be sent to the Secretariat until April 22, 2022. After this date, no cancelation will be accepted.

    - Reimbursement for the amount paid will be made up to 60 days after the conference and it will correspond to 60% of the amount paid.

    - Click here to download the request for reimbursement.

    - Please send the request properly signed and scanned to the email: eventos@abhh.org.br

  • The access to the broadcasting platform will be through the link: https://www.abhheventos.com/blc2022/blc2022-login, please use the data entered at registration (email and password). You will be able to access it from April 26th.

  • Please access our chat, on the bottom right icon of the website. If you prefer, you can reach us through email: eventos@abhh.org.br. In case you need support during the broadcasting, our communication channels will be available.

  • If you are trying to enter your password but it is not right, you should be driven to other page to recover your password.

  • Please try again or use a different email address you often use.

  • A certificate will be awarded to all attendees. It should be available 7 days after the event. Please access the Restricted Area of this website using your email and password registered. *It is mandatory to have attended to 70% of total workload of the conference.

  • Lectures will be available through a link and will be made available to all attendees 30 days after the conference. ABHH members may access as well through Hemoteca on the website site www.abhh.org.br in the Education Section.

  • • Use the Google Chrome browser.
    • Check if the place chosen has a good internet signal and if your computer battery is loaded (or make sure you are close to a power source).
    • Test your connection through the internet address: www.speedtest.net
    • If you are using the company computer, it may have safety protocols that might interfere. If that is the case, please use your personal computer.
    • Choose your desktop over a tablet or mobile device.
    • Close all the windows and software not necessary to access the event.
    • Make sure every pop-up blockage software on your browser is off.
    • Remember to disable the VPN in your computer settings.
    • Try an incognito window on your web browser.
    • Choosing a calm place, and if possible a quiet place, will help in your concentration.
    • Access the conference link 1 hour in advance, so you can check the places available in the platform.
    • Use the programme breaks to stretching, drinking some water, checking your messages, etc.
    • Remember to interact through the chat and interaction tools.

Sponsors

Gold

Silver

Bronze

Support

Institutional Support